About Molbio Diagnostics Ltd
Molbio Diagnostics are an innovative point-of-care (“POC”) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
Founded
2000
CEO
SRIRAM NATARAJAN
Employees
346
HQ
Goa, India
Finished Products
1Sales of Products
₹953.23Cr2Other operating revenues
₹18.00CrRaw Materials
1Cost of Material Consumed
₹384.42Cr2Purchases of Stock in Trade
₹24.18CrAbout Molbio Diagnostics Ltd
Molbio Diagnostics are an innovative point-of-care (“POC”) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
Founded:2000
CEO:SRIRAM NATARAJAN
Employees:346
HQ:Goa, India
Finished Products
1Sales of Products
₹953.23Cr2Other operating revenues
₹18.00CrRaw Materials
1Cost of Material Consumed
₹384.42Cr2Purchases of Stock in Trade
₹24.18CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,265
52W Low
₹926
Volume1.87M
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
86.82x
Valuation
P/B Ratio
10.20x
Valuation
EPS
₹12.13
Valuation
Dividend Yield
0.00%
Valuation
ROE
14.12%
Profitability
ROCE
19.35%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
90.4%
International
9.6%
India90.4%
Outside India9.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.03x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
20.0%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.